Gornitzky represented the underwriters, led by Cowen and Company and Wells Fargo Securities, in the USD 25 million follow-on offering of MediWound Ltd. on the NASDAQ Global Market. MediWound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications.
Cowen and Company, LLC and Wells Fargo Securities, LLC acted as joint book-running managers for the offering. Oppenheimer & Co. Inc. and SunTrust Robinson Humphrey, Inc. acted as co-lead managers for the offering. Aegis Capital Corp. acted as a co-manager for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Sagit Amit Evan (Senior Associate), together with Associates Danielle Skald and Daniella Segal.
